Darin Lippoldt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sumitomo Mitsui Trust Holdings Inc. increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 5.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 243,935 shares of the company’s stock after purchasing an additional 12,382 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Neurocrine Biosciences were worth $32,141,000 […]

Assenagon Asset Management S.A. lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 315,560 shares of the company’s stock after selling 268,979 shares during the quarter. Assenagon Asset Management […]

WINTON GROUP Ltd grew its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 68.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,272 shares of the company’s stock after acquiring an additional 1,738 shares during the period. WINTON GROUP Ltd’s […]

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Investment analysts at Cantor Fitzgerald upped their FY2024 earnings per share estimates for shares of Neurocrine Biosciences in a research report issued on Thursday, February 8th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will post earnings per share of $5.05 for the year, up […]

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Stock analysts at Cantor Fitzgerald lifted their FY2024 earnings estimates for Neurocrine Biosciences in a report issued on Thursday, February 8th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will earn $5.05 per share for the year, up from their prior forecast of $4.85. Cantor […]